253 related articles for article (PubMed ID: 6428842)
1. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
[TBL] [Abstract][Full Text] [Related]
2. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
Kolterman OG; Olefsky JM
Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
[TBL] [Abstract][Full Text] [Related]
3. Sulfonylurea effects on target tissues for insulin.
McCaleb ML; Maloff BL; Nowak SM; Lockwood DH
Diabetes Care; 1984; 7 Suppl 1():42-6. PubMed ID: 6376028
[TBL] [Abstract][Full Text] [Related]
4. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
DeFronzo RA; Simonson DC
Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
[TBL] [Abstract][Full Text] [Related]
5. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
[TBL] [Abstract][Full Text] [Related]
6. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
7. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
Graham JP; Stam D
Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
[TBL] [Abstract][Full Text] [Related]
8. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
[TBL] [Abstract][Full Text] [Related]
9. Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide.
Grunberger G
J Lab Clin Med; 1993 Apr; 121(4):555-61. PubMed ID: 8454937
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
11. Non-insulin-dependent diabetes mellitus: a clinical strategy.
Skyler JS
Diabetes Care; 1984; 7 Suppl 1():118-29. PubMed ID: 6376024
[TBL] [Abstract][Full Text] [Related]
12. Oral hypoglycemic agents in the treatment of type II diabetes.
Tal A
Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
Ponte CD
W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
[TBL] [Abstract][Full Text] [Related]
14. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
15. Cellular loci of sulfonylurea actions.
Lebovitz HE
Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
[TBL] [Abstract][Full Text] [Related]
16. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
17. [Indications and methods of treatment with sulfonylureas in NIDDM patients].
Cortinovis A; Crippa A
Minerva Med; 1991 Dec; 82(12):833-40. PubMed ID: 1780090
[TBL] [Abstract][Full Text] [Related]
18. [Oral antidiabetic agents: recent aspects].
Keller U; Berger W
Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
Procacci V; Giovine A; Roberto MG; Di Reda N; Lasorsa G; Vendemiale G; Stufano N; Altomare E
Boll Soc Ital Biol Sper; 1988 Sep; 64(9):817-24. PubMed ID: 3072977
[No Abstract] [Full Text] [Related]
20. Effect of glyburide on metabolic control and insulin binding in insulin-dependent diabetes mellitus.
Goldman J; Tamayo RC; Whitehouse FW; Kahkonen DM
Diabetes Care; 1984; 7 Suppl 1():106-12. PubMed ID: 6428843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
